Trial Profile
A proof-of-mechanism, electrophysiology phase I study of XEN D0101.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2011
Price :
$35
*
At a glance
- Drugs XEN D0101 (Primary)
- Indications Atrial fibrillation
- Focus Pharmacodynamics
- 12 Sep 2011 New trial record